Glenmede Trust CO Na Veracyte, Inc. Transaction History
Glenmede Trust CO Na
- $19.6 Billion
- Q2 2024
Shares
4 transactions
Others Institutions Holding VCYT
# of Institutions
254Shares Held
82.1MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$263 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.5MShares$253 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$232 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.81MShares$230 Million1.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.46MShares$117 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.42B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...